Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	2.11e-20	114	211	21	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.33e-19	124	211	21	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.15e-18	137	211	21	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 TRHDE USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 CAPN15	7.17e-18	192	211	23	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 TRHDE USP17L4 USP17L2 USP17L12 LONP2 USP17L11 USP17L24 USP43 SHH USP17L5 USP17L10 ADAMTS7 USP17L6P ELANE USP17L22 USP17L15 USP17L8 CAPN15	1.53e-09	654	211	27	GO:0008233
GeneOntologyMolecularFunction	SUMO polymer binding	SIMC1 SOBP RNF4	2.27e-05	6	211	3	GO:0032184
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	6.78e-20	125	209	21	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.44e-18	144	209	21	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 FBXO38 ZNRF3 USP17L17 ASB6 KLHL21 USP17L3 USP17L13 TRIM72 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 RNF126 CRY1 RNF4 USP17L6P DCAF11 USP17L22 USP17L15 USP17L8	1.20e-07	1009	209	30	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 FBXO38 ZNRF3 USP17L17 ASB6 KLHL21 USP17L3 USP17L13 TRIM72 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 RNF126 CRY1 RNF4 USP17L6P DCAF11 USP17L22 USP17L15 USP17L8	4.54e-07	1074	209	30	GO:0043687
GeneOntologyBiologicalProcess	chromosome movement towards spindle pole	KATNB1 ACTR2 FMN2	3.48e-05	7	209	3	GO:0051305
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 ZDHHC2 USP17L21 USP17L1 USP17L20 USP17L19 PTGFRN ITPR3 USP17L18 PNPLA6 USP17L17 TMEM259 RAB3GAP2 USP17L3 ATG9A USP17L13 ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 SHH USP17L5 USP17L10 PLA2G4C PAFAH2 USP17L6P FMN2 USP17L22 TNPO3 USP17L15 USP17L8	1.42e-06	1327	211	33	GO:0042175
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 ZDHHC2 USP17L21 USP17L1 USP17L20 USP17L19 PTGFRN ITPR3 USP17L18 PNPLA6 USP17L17 TMEM259 RAB3GAP2 USP17L3 ATG9A USP17L13 ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 SHH USP17L5 USP17L10 PLA2G4C PAFAH2 USP17L6P FMN2 USP17L22 USP17L15 USP17L8	2.32e-06	1293	211	32	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 ZDHHC2 USP17L21 USP17L1 USP17L20 USP17L19 PTGFRN ITPR3 USP17L18 PNPLA6 USP17L17 TMEM259 RAB3GAP2 USP17L3 ATG9A USP17L13 ATP8B3 USP17L4 STIM2 USP17L2 USP17L12 USP17L11 SHH USP17L5 USP17L10 PLA2G4C PAFAH2 USP17L6P FMN2 USP17L22 USP17L15 USP17L8	2.56e-06	1299	211	32	GO:0098827
GeneOntologyCellularComponent	adherens junction	PGM5 DDX6 SHROOM4 DLG3 PLEKHA7 SHROOM3 SYNM PALS1 TJP1 IGSF21	6.16e-05	212	211	10	GO:0005912
GeneOntologyCellularComponent	cell cortex	SHROOM4 DLC1 HMCN2 MICAL3 PDZD4 SHROOM3 ANK1 HIP1R SAPCD2 ACTR2 PLA2G4C FMN2	4.10e-04	371	211	12	GO:0005938
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22	3.18e-26	16	207	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22	3.18e-26	16	207	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	1.60e-21	71	207	19	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	1.60e-21	71	207	19	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	2.15e-21	72	207	19	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	2.15e-21	72	207	19	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	2.15e-21	72	207	19	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	1.29e-20	66	207	18	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP43 USP17L5 USP17L10 USP17L22 USP17L8	4.21e-20	70	207	18	PS00972
Domain	Ig-like_fold	EPHB6 KIRREL2 PTGFRN HMCN2 NFATC2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 PLXNB1 EBF4 NPHS1 HSPG2 SDK2 SNED1 CD2 CEACAM16 IGSF21 ANKFN1 CD300E TNXB EPHA10	1.12e-06	706	207	24	IPR013783
Domain	-	EPHB6 KIRREL2 PTGFRN NFATC2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 PLXNB1 EBF4 NPHS1 HSPG2 SDK2 SNED1 CD2 CEACAM16 IGSF21 ANKFN1 CD300E TNXB EPHA10	1.35e-06	663	207	23	2.60.40.10
Domain	ig	PTGFRN KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 NPHS1 HSPG2 SDK2 IGSF21	5.30e-05	190	207	10	PF00047
Domain	Immunoglobulin	PTGFRN KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 NPHS1 HSPG2 SDK2 IGSF21	5.30e-05	190	207	10	IPR013151
Domain	IG	KIRREL2 PTGFRN HMCN2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 NPHS1 HSPG2 SDK2 CEACAM16 IGSF21 CD300E	7.49e-05	421	207	15	SM00409
Domain	Ig_sub	KIRREL2 PTGFRN HMCN2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 NPHS1 HSPG2 SDK2 CEACAM16 IGSF21 CD300E	7.49e-05	421	207	15	IPR003599
Domain	Ig-like_dom	KIRREL2 PTGFRN HMCN2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1 NPHS1 HSPG2 SDK2 CD2 CEACAM16 IGSF21 CD300E	1.61e-04	503	207	16	IPR007110
Domain	IG_LIKE	KIRREL2 PTGFRN HMCN2 ROBO3 KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 NPHS1 HSPG2 SDK2 CD2 CEACAM16 IGSF21 CD300E	3.96e-04	491	207	15	PS50835
Domain	EGF_CA	TPO HMCN2 VWA2 HSPG2 SNED1 CELSR3 CCBE1	4.24e-04	122	207	7	SM00179
Domain	fn3	EPHB6 ROBO3 NPHS1 SDK2 SNED1 ANKFN1 TNXB EPHA10	4.57e-04	162	207	8	PF00041
Domain	EGF-like_Ca-bd_dom	TPO HMCN2 VWA2 HSPG2 SNED1 CELSR3 CCBE1	4.68e-04	124	207	7	IPR001881
Domain	-	STARD9 TCF19 PHF12 SNIP1	6.54e-04	36	207	4	2.60.200.20
Domain	FHA_dom	STARD9 TCF19 PHF12 SNIP1	6.54e-04	36	207	4	IPR000253
Domain	EGF-like_CS	TPO HMCN2 VWA2 HSPG2 SNED1 CELSR3 CCBE1 NAGPA TNXB EPHA10	6.88e-04	261	207	10	IPR013032
Domain	Shroom_fam	SHROOM4 SHROOM3	7.23e-04	4	207	2	IPR027685
Domain	ASD2_dom	SHROOM4 SHROOM3	7.23e-04	4	207	2	IPR014799
Domain	ASD2	SHROOM4 SHROOM3	7.23e-04	4	207	2	PF08687
Domain	ASD2	SHROOM4 SHROOM3	7.23e-04	4	207	2	PS51307
Domain	EGF_2	TPO HMCN2 VWA2 HSPG2 SNED1 CELSR3 CCBE1 NAGPA TNXB EPHA10	7.73e-04	265	207	10	PS01186
Domain	PDZ	SHROOM4 DLG3 PDZD4 SHROOM3 PALS1 TJP1 PDZD2	1.00e-03	141	207	7	PF00595
Domain	FN3	EPHB6 ROBO3 NPHS1 SDK2 SNED1 ANKFN1 TNXB EPHA10	1.09e-03	185	207	8	SM00060
Domain	SAPAP	DLGAP2 DLGAP1	1.20e-03	5	207	2	IPR005026
Domain	GKAP	DLGAP2 DLGAP1	1.20e-03	5	207	2	PF03359
Domain	EGF_3	TPO HMCN2 VWA2 HSPG2 SNED1 CELSR3 CCBE1 NAGPA TNXB	1.27e-03	235	207	9	PS50026
Domain	PDZ	SHROOM4 DLG3 PDZD4 SHROOM3 PALS1 TJP1 PDZD2	1.33e-03	148	207	7	SM00228
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	5.46e-26	45	158	19	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	4.01e-13	191	158	19	MM15289
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 DLG3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 KSR2 USP17L5 USP17L10 USP17L6P IRS2 USP17L22 USP17L15 USP17L8	8.10e-12	318	158	22	MM15278
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8	5.07e-11	221	158	18	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.07e-10	262	158	19	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 USP17L8	6.71e-09	299	158	18	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 THSD1 GFPT1 USP17L18 ST3GAL6 USP17L17 ASB6 KLHL21 FBXO41 USP17L3 NUP160 USP17L13 USP17L4 USP17L2 ANK1 USP17L12 RCCD1 MAN1C1 USP17L11 AMDHD2 USP17L5 USP17L10 KLHL5 GALNT17 RAB34 ADAMTS7 USP17L6P DCAF11 USP17L22 USP17L15 USP17L8	3.44e-06	1389	158	35	MM15307
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 USP17L1 USP17L20 USP17L19 THSD1 GFPT1 USP17L18 ST3GAL6 USP17L17 ASB6 KLHL21 FBXO41 USP17L3 NUP160 USP17L13 USP17L4 USP17L2 ANK1 USP17L12 RCCD1 MAN1C1 USP17L11 USP17L24 AMDHD2 USP17L5 USP17L10 KLHL5 GALNT17 RAB34 ADAMTS7 DCAF11 USP17L22 USP17L15 USP17L8	3.25e-05	1475	158	34	M19806
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.89e-41	21	215	19	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	7.21e-40	22	215	19	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.97e-38	24	215	19	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	8.16e-38	25	215	19	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.02e-37	26	215	19	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.44e-36	33	215	20	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.47e-36	34	215	20	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	8.05e-36	35	215	20	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	8.05e-36	35	215	20	21239494
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	9.04e-36	29	215	19	32527007
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.80e-35	36	215	20	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.90e-35	37	215	20	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	1.23e-29	50	215	19	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8	8.33e-17	10	215	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8	9.07e-16	12	215	8	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8	5.44e-15	14	215	8	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L6P USP17L15 USP17L8	1.33e-13	19	215	8	28067227
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 DLGAP1 USP17L1 USP17L20 USP17L19 USP17L18 SHROOM4 USP17L17 USP17L3 SHE TAL1 USP17L13 CACNA1C USP17L4 USP17L2 ANK1 USP17L12 USP17L11 USP17L5 USP17L10 PLA2G4C USP17L6P USP17L22 USP17L15 USP17L8	1.35e-13	674	215	26	37196079
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP43 USP17L6P USP17L15 USP17L8	1.98e-09	81	215	9	12838346
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP1 ARHGEF17 DDX6 CDR2L DLC1 STARD9 RAB3GAP2 PLEKHA7 MEX3B DIP2B SHROOM3 STIM2 USP43 MLXIP NCKAP5L VPS13D INA FAM171A2 TJP1 PLEKHG3 FMN2 IRS2 TNPO3	4.87e-09	861	215	23	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ITPR3 CDR2L PNPLA6 ZNRF3 TMEM259 KLHL21 MICAL3 ATG9A METTL27 PRRC2B HSPG2 SHROOM3 PHF12 KSR2 HIP1R MLXIP SH2B2 MBD3 KANSL1 CELSR3 ADAMTS7 BTBD7 IRS2 WDFY3 TNPO3 PCNT	6.25e-09	1105	215	26	35748872
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.59e-09	12	215	5	20137308
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.65e-08	14	215	5	19875891
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.65e-08	14	215	5	19489269
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.65e-08	14	215	5	15896204
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.65e-08	14	215	5	18945962
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.46e-08	15	215	5	20082646
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.46e-08	15	215	5	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.46e-08	15	215	5	19926642
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.46e-08	15	215	5	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.46e-08	15	215	5	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	19309280
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.56e-08	16	215	5	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	20650299
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	19032228
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	20483367
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	19218127
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	5.02e-08	17	215	5	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.92e-08	18	215	5	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.92e-08	18	215	5	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.92e-08	18	215	5	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.92e-08	18	215	5	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.92e-08	18	215	5	19846535
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	9.34e-08	19	215	5	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	9.34e-08	19	215	5	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	9.34e-08	19	215	5	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	9.34e-08	19	215	5	18848853
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DS1 KIR3DL1 KIR3DL2 KIR3DS1	9.75e-08	8	215	4	9430221
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.24e-07	20	215	5	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.24e-07	20	215	5	20426625
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.62e-07	21	215	5	19861144
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.75e-07	9	215	4	8662091
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	1.75e-07	9	215	4	18340360
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	2.08e-07	22	215	5	20492596
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DL2 KIR3DS1	2.33e-07	3	215	3	11859120
Pubmed	KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.	KIR2DS4 KIR3DL1 KIR3DS1	2.33e-07	3	215	3	19859704
Pubmed	Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.	KIR3DL1 KIR3DL2 KIR3DS1	2.33e-07	3	215	3	19019897
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PDZD4 DIP2B SHROOM3 STIM2 SDK2 PHF12 BTBD7 PLCE1	2.69e-07	103	215	8	10819331
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	2.90e-07	10	215	4	21206914
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	4.53e-07	11	215	4	19664392
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 DLGAP2 USP17L1 USP17L3 USP17L4 USP17L8	5.14e-07	48	215	6	16421571
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DLGAP2 DLGAP1 FARSA TMEM259 ZC3H4 FBXO41 DLG3 PRRC2B SH3BP5 CACNA1A DIP2B SHROOM3 KSR2 MBD3 KIF7 PALS1 INA FAM171A2 TJP1 WDFY3 PCNT	6.76e-07	963	215	21	28671696
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	6.76e-07	12	215	4	20371502
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	6.76e-07	12	215	4	17490516
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	6.76e-07	12	215	4	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DS1	6.76e-07	12	215	4	19181658
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	9.07e-07	29	215	5	20082482
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L13 USP17L2 USP17L15	9.28e-07	4	215	3	22984479
Pubmed	Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.	KIR3DL1 KIR3DL2 KIR3DS1	9.28e-07	4	215	3	27455421
Pubmed	A FRET Sensor to Monitor Bivalent SUMO-SIM Interactions in SUMO Chain Binding.	SIMC1 SOBP RNF4	9.28e-07	4	215	3	29120074
Interaction	YWHAG interactions	DLGAP1 HIVEP1 ARHGEF17 RUVBL2 DDX6 CDR2L DLC1 NFATC2 STARD9 SIMC1 ATG9A PLEKHA7 MEX3B SHROOM3 STIM2 KSR2 SH2D3C USP43 MLXIP NCKAP5L ACTR2 KIF7 LGALS8 SNIP1 VPS13D INA FAM171A2 TJP1 PLEKHG3 FMN2 IRS2 TNPO3	1.39e-06	1248	206	32	int:YWHAG
Interaction	YWHAH interactions	DLGAP1 HIVEP1 ARHGEF17 DDX6 CDR2L STARD9 RAB3GAP2 ATG9A PLEKHA7 MEX3B DIP2B SHROOM3 STIM2 KSR2 USP43 MLXIP NCKAP5L ACTR2 KIF7 CRY1 SLX9 VPS13D INA FAM171A2 TJP1 PLEKHG3 FMN2 IRS2 PCNT	2.78e-06	1102	206	29	int:YWHAH
Cytoband	4p16.1	USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15	1.51e-18	79	215	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 RNF4 USP17L6P USP17L22 USP17L15	2.20e-13	222	215	15	chr4p16
Cytoband	19q13.4	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	3.66e-05	79	215	5	19q13.4
Cytoband	17q25.1	QRICH2 CDR2L SDK2 FADS6 CD300E	4.13e-05	81	215	5	17q25.1
Cytoband	8p23.1	USP17L7 USP17L1 USP17L3 USP17L4 USP17L2 USP17L8	9.28e-05	154	215	6	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 DLGAP2 USP17L1 USP17L3 USP17L4 USP17L2 USP17L8	1.27e-04	234	215	7	chr8p23
Cytoband	19p13.3	PLK5 TMEM259 ATP8B3 POLR2E RNF126 MBD3 ELANE	1.38e-04	237	215	7	19p13.3
Cytoband	16p13.3	CORO7 MPG HAGHL AMDHD2 NAGPA SEC14L5 CAPN15	1.64e-04	244	215	7	16p13.3
Cytoband	14q22.2	SLC35F4 WDHD1	9.58e-04	10	215	2	14q22.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	ERCC4 CORO7 MPG HAGHL AMDHD2 NAGPA SEC14L5 CAPN15	9.66e-04	426	215	8	chr16p13
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	PLK5 FARSA PNPLA6 TMEM259 CACNA1A ATP8B3 POLR2E RNF126 MBD3 SLC1A6 ELANE	1.45e-03	797	215	11	chr19p13
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	ANKRD65 KLHL21 SCNN1D HSPG2 MAN1C1 C1orf167 VPS13D PAFAH2 IGSF21 HSPB7	1.51e-03	681	215	10	chr1p36
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS1 KIR2DS4 KIR3DL1 KIR3DL2 KIR3DS1	1.65e-07	18	134	5	620
GeneFamily	Immunoglobulin like domain containing	KIRREL2 PTGFRN HMCN2 ROBO3 NPHS1 HSPG2 SDK2 CEACAM16 IGSF21	1.38e-05	193	134	9	594
GeneFamily	Fibronectin type III domain containing	EPHB6 ROBO3 NPHS1 SDK2 SNED1 ANKFN1 TNXB EPHA10	2.56e-05	160	134	8	555
GeneFamily	PDZ domain containing	SHROOM4 DLG3 PDZD4 SHROOM3 PALS1 TJP1 PDZD2	1.39e-04	152	134	7	1220
GeneFamily	Intermediate filaments Type IV	SYNM INA	8.02e-04	6	134	2	611
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	DLG3 PALS1 TJP1	9.14e-04	26	134	3	904
GeneFamily	Adenosine receptors\|V-set domain containing	PTGFRN NPHS1 CD2 CEACAM16 IGSF21 CD300E	1.36e-03	163	134	6	590
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	KIRREL2 NPHS1 CD2	3.22e-03	40	134	3	592
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 SHE USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	8.00e-24	86	214	20	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 THSD1 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	2.37e-21	112	214	20	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	7.03e-17	160	214	19	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 CDR2L USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 SH2D3C USP17L5 USP17L10 ADAMTS7 USP17L6P USP17L22 USP17L15 USP17L8	1.95e-08	647	214	22	MM981
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 USP17L21 CNNM2 USP17L1 USP17L20 VPS33A USP17L19 DDX6 USP17L18 ST3GAL6 USP17L17 USP17L3 ROBO3 USP17L13 CACNA1C USP17L4 USP17L2 TCF19 USP17L12 USP17L11 USP17L5 USP17L10 LGALS8 CELSR3 USP17L6P USP17L22 USP17L15 USP17L8	5.75e-07	1198	214	28	MM1062
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 USP17L21 USP17L1 USP17L20 GIMAP5 USP17L19 GFPT1 USP17L18 USP17L17 NFATC2 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 CHD1L ITIH5 LGALS8 CD2 USP17L6P USP17L22 USP17L15 USP17L8	7.61e-07	1072	214	26	MM1031
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 CDR2L USP17L17 NFATC2 SIMC1 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 SH2D3C USP17L5 USP17L10 SLX9 RNF4 ADAMTS7 USP17L6P USP17L22 USP17L15 USP17L8	8.66e-06	1226	214	26	MM979
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN	GIMAP5 THSD1 PGM5 SHROOM4 STARD9 SHE SH3BP5 SYNM PALS1 KLHL5 CD2 RSPO1 CD300E TNXB PDZD2	1.38e-05	491	214	15	MM455
Coexpression	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	EPHB6 RPS4X LAPTM4B ARHGEF17 RUVBL2 FARSA PNPLA6 PTPRN KLHL21 ATG9A PRRC2B POLR2E MBD3 FAN1 INA RNF4 NAGPA SEC14L5 PCNT	1.54e-05	755	214	19	M2105
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	PLK5 SMOC1 KIRREL2 ARHGEF17 BDNF PGM5 ITPR3 DLC1 NFATC2 SHE EBF4 TRHDE SHROOM3 SAPCD2 SNED1 INA ADAMTS7 PLEKHG3 CCBE1 ATOH8 NR2E1 IGSF21 RSPO1	2.55e-05	1074	214	23	M1941
Coexpression	ZHONG_PFC_C3_MICROGLIA	DLG3 EBF4 CACNA1A CACNA1C SDK2 HAGHL SOBP HIP1R INA CCBE1 FMN2 IRS2 IGSF21 EPHA10	5.30e-05	488	214	14	M39104
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 PGM5 MICAL3 TRHDE CACNA1C SDK2 ITIH5 SNED1 GALNT17 CCBE1 TNXB	8.51e-10	180	206	11	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNNM2 ARHGEF17 DLC1 STARD9 CACNA1C SYNM ITIH5 TJP1 PLCE1 PDZD2	1.13e-08	178	206	10	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 PGM5 TRHDE CACNA1C SDK2 ITIH5 SNED1 GALNT17 CCBE1 TNXB	1.26e-08	180	206	10	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	DLGAP2 THSD1 SMOC1 PGM5 SHE MICAL3 TAL1 SYNM SH2D3C TNXB	2.11e-08	190	206	10	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PGM5 STARD9 SHE TAL1 SH3BP5 HSPG2 SH2D3C SNED1 KLHL5 TNXB	2.98e-08	197	206	10	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 GIMAP5 THSD1 SMOC1 PGM5 SHE ROBO3 TAL1 SH2D3C P3H2	3.12e-08	198	206	10	306e28d31fd587409a12dcccc6b2abd7dc9c2e0a
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_lymphatic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 GIMAP5 THSD1 SMOC1 PGM5 SHE ROBO3 TAL1 SH2D3C P3H2	3.12e-08	198	206	10	05429f18e1d74880c1835568c86177f661b3477a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma\|TCGA-Brain / Sample_Type by Project: Shred V9	PDZD4 ANK1 KSR2 HIP1R INA CELSR3 ATOH8 SRRM3 EPHA10	6.49e-08	161	206	9	5f6b2d7f80a8ee16651e304481d2da3fae313824
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP\|bone_marrow / Manually curated celltypes from each tissue	ANKRD65 LAPTM4B PGM5 DLC1 TAL1 VWA2 MEX3B SLC1A6 PDZD2	8.44e-08	166	206	9	9788486582cc2c5f28b9ea015e235732f9fefb1e
ToppCell	Healthy_donor-HSPC\|World / disease group, cell group and cell class (v2)	DLGAP2 LAPTM4B ARHGEF17 PLEKHA7 MEX3B PLXNB1 CACNA1C HSPG2 FAM171A2	8.89e-08	167	206	9	70630ebdfee8171d625811844f8a7c94736d101e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIRREL2 ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	1.85e-07	182	206	9	cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP2 ABCA4 PGM5 ST3GAL6 SHE ROBO3 SYNM SH2D3C TNXB	1.94e-07	183	206	9	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIRREL2 ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.23e-07	186	206	9	1094c7140131454b2583200e1c01e81ccab3db23
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175\|Adult / Lineage, Cell type, age group and donor	DLGAP2 SMOC1 PGM5 SHE MICAL3 TAL1 SYNM SH2D3C HSPB7	2.33e-07	187	206	9	1e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PGM5 STARD9 SHE SH3BP5 HSPG2 SH2D3C SNED1 KLHL5 TNXB	2.33e-07	187	206	9	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP2 SMOC1 PGM5 MICAL3 TAL1 SYNM SH2D3C SNED1 TNXB	2.66e-07	190	206	9	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIRREL2 ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.91e-07	192	206	9	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP2 SMOC1 PTPRN CACNA1A SLC35F4 INA CELSR3 SRRM3	3.34e-07	142	206	8	819e983688d126d89a71abc03d72525cc759a347
ToppCell	wk_15-18-Endothelial-Lymph_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ABCA4 GIMAP5 THSD1 SMOC1 PGM5 SHE SYNM PLA2G4C TNXB	3.46e-07	196	206	9	ff627244d7f5fd6a2ec009dae32d3509f0e2d95e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PGM5 DLC1 STARD9 SHE SH3BP5 HSPG2 SH2D3C SNED1 KLHL5	3.77e-07	198	206	9	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	DLGAP2 ABCA4 SMOC1 PGM5 SHE TAL1 HSPG2 SYNM TNXB	3.94e-07	199	206	9	88f33b8dcd837abfa1d12c28719e073a7da6e979
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DLGAP2 ABCA4 SMOC1 PGM5 SHE TAL1 HSPG2 SYNM TNXB	3.94e-07	199	206	9	64b19aff72e2a109cb5857cb248bd4712dd49b43
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DLGAP2 ABCA4 SMOC1 PGM5 SHE TAL1 HSPG2 SYNM TNXB	3.94e-07	199	206	9	2b9e1e069b36b3a61cc3e384f4523687b0e03905
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	TPO STARD9 TAL1 SH3BP5 SYNM SH2D3C PLA2G4C CELSR3	1.14e-06	167	206	8	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	1.31e-06	170	206	8	60bbd738c12e64e483485586c30057304884f5a6
ToppCell	Healthy_donor-HSPC\|Healthy_donor / disease group, cell group and cell class (v2)	DLGAP2 LAPTM4B ARHGEF17 PLEKHA7 MEX3B PLXNB1 CACNA1C FAM171A2	1.43e-06	172	206	8	bc7549faadfc92c683c0e26bea380458706774b5
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ST3GAL6 ZNRF3 NPHS1 ITIH5 P3H2 CCBE1 FMN2 PLCE1	1.63e-06	175	206	8	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP\|lymph-node_spleen / Manually curated celltypes from each tissue	LAPTM4B DLC1 TAL1 VWA2 TRHDE HSPG2 ANK1 SLC1A6	1.70e-06	176	206	8	23a8ec42ebd42c539865a12d09773af90f3f8848
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SMOC1 KCNG2 CRH KLHL5 GALNT17 CCBE1 NR2E1 PLCE1	1.93e-06	179	206	8	01302505816f272243659e20d751b61a198a2fc0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BDNF ST3GAL6 NPHS1 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.01e-06	180	206	8	d685fa2b013bc085dbef7c40956ed3043f83e483
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 PGM5 TRHDE CACNA1C ITIH5 SNED1 CCBE1 ELANE	2.09e-06	181	206	8	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GDF6 PGM5 ITIH5 SLC35F4 CCBE1 FMN2 RSPO1 HSPB7	2.09e-06	181	206	8	ab0f300d14b62cef57f1b0bdae143b8dfe8e6975
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 SLC35F4 TJP1 CCBE1 FMN2 PLCE1	2.27e-06	183	206	8	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.27e-06	183	206	8	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.27e-06	183	206	8	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.27e-06	183	206	8	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.36e-06	184	206	8	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF17 SH3BP5 KIF7 SLC35F4 RAB34 CCBE1 ANKFN1 TNXB	2.46e-06	185	206	8	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP2 ABCA4 THSD1 SMOC1 PGM5 SHE SYNM PLA2G4C	2.46e-06	185	206	8	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.46e-06	185	206	8	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KIRREL2 ST3GAL6 NPHS1 ITIH5 TJP1 CCBE1 FMN2 PLCE1	2.77e-06	188	206	8	9db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	DLGAP2 THSD1 SMOC1 PGM5 SHE SYNM SH2D3C TNXB	2.77e-06	188	206	8	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	2.77e-06	188	206	8	047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP2 ABCA4 THSD1 SMOC1 PGM5 SHE SYNM SH2D3C	2.88e-06	189	206	8	55a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	TPO DLGAP2 ABCA4 SMOC1 PGM5 TAL1 SYNM TNXB	3.00e-06	190	206	8	8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TPO BDNF PGM5 DLC1 CACNA1C SYNM HSPB7 PDZD2	3.00e-06	190	206	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PGM5 STARD9 SHE TAL1 SH3BP5 SH2D3C KLHL5 TNXB	3.12e-06	191	206	8	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DLGAP1 PGM5 TRHDE CACNA1C SNED1 GALNT17 TNXB GASK1A	3.12e-06	191	206	8	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD9 SHE TAL1 SH3BP5 HSPG2 SH2D3C SNED1 KLHL5	3.24e-06	192	206	8	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PTPRN FBXO41 DLG3 CACNA1A SRRM3 EPHA10	3.37e-06	193	206	8	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PTPRN FBXO41 DLG3 CACNA1A SRRM3 EPHA10	3.37e-06	193	206	8	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 ITIH5 PALS1 TJP1 CCBE1 FMN2 PLCE1	3.37e-06	193	206	8	3eaa0461618582a1754400624350d269d24e750a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP1 DLC1 TRHDE CACNA1C SDK2 GALNT17 CCBE1 TNXB	3.37e-06	193	206	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP2 DLGAP1 PTPRN FBXO41 DLG3 CACNA1A SRRM3 EPHA10	3.37e-06	193	206	8	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 STARD9 SHE TAL1 SH3BP5 HSPG2 SH2D3C SNED1	3.50e-06	194	206	8	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 STARD9 SHE TAL1 SH3BP5 HSPG2 SH2D3C SNED1	3.50e-06	194	206	8	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP1 TRHDE CACNA1C SDK2 MAN1C1 SNED1 GALNT17 CCBE1	3.50e-06	194	206	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLC1 STARD9 SHE TAL1 SH3BP5 HSPG2 SH2D3C SNED1	3.50e-06	194	206	8	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Striatum / BrainAtlas - Mouse McCarroll V32	GIMAP5 THSD1 ITPR3 SHROOM4 SHE TAL1 USP43	3.54e-06	137	206	7	306b11b3b9e5fd562d845fb5eaa4ac982864efce
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK\|Striatum / BrainAtlas - Mouse McCarroll V32	GIMAP5 THSD1 ITPR3 SHROOM4 SHE TAL1 USP43	3.54e-06	137	206	7	d37f425b13bc046baa1f8619b98a16b936f88ff6
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	DLC1 TRHDE CACNA1C ITIH5 SNED1 GALNT17 CCBE1 TNXB	3.64e-06	195	206	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 ABCA4 THSD1 PGM5 SHE TAL1 SH2D3C PLA2G4C	3.78e-06	196	206	8	09a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 ABCA4 THSD1 PGM5 SHE TAL1 SH2D3C PLA2G4C	3.78e-06	196	206	8	e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	TPO SHROOM4 STARD9 SH3BP5 SH2D3C KLHL5 PLA2G4C TJP1	3.78e-06	196	206	8	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	severe-Lymphocytic-NK_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPS4X NFATC2 KIR2DS4 KIR3DL1 KIR3DL2 PDZD4 CD2 AUTS2	3.92e-06	197	206	8	8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF17 DLC1 CACNA1A CACNA1C SYNM ITIH5 PLA2G4C HSPB7	4.07e-06	198	206	8	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 SMOC1 PGM5 MICAL3 TAL1 SYNM SH2D3C PLEKHG3	4.07e-06	198	206	8	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DLGAP2 DLGAP1 CACNA1A CACNA1C KSR2 GALNT17 FMN2 SRRM3	4.07e-06	198	206	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DLGAP2 DLGAP1 CACNA1A CACNA1C KSR2 GALNT17 FMN2 SRRM3	4.07e-06	198	206	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DLGAP2 DLGAP1 CACNA1A CACNA1C KSR2 GALNT17 FMN2 SRRM3	4.07e-06	198	206	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	control-Lymphocytic-NK_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPS4X NFATC2 KIR2DS4 KIR3DL1 KIR3DL2 PDZD4 CD2 AUTS2	4.07e-06	198	206	8	1c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLGAP2 SMOC1 PGM5 MICAL3 TAL1 SYNM SH2D3C PLEKHG3	4.07e-06	198	206	8	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD1 SHROOM4 TAL1 SH3BP5 SH2D3C ITIH5 TJP1 TNXB	4.22e-06	199	206	8	7ed541309808f15d65a9c4b26be2050e077539e6
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	THSD1 SHE TAL1 CACNA1C SH2D3C PLA2G4C TNXB	5.15e-06	145	206	7	ffbdadea0185e5d3b85f2868d5ec82b50cf2e2a1
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	PGM5 HMCN2 SYNM SOBP ITIH5 ELANE TNXB	9.83e-06	160	206	7	8a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	PGM5 HMCN2 SYNM SOBP ITIH5 ELANE TNXB	9.83e-06	160	206	7	c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCell	TCGA-Bladder-Solid_Tissue_Normal\|TCGA-Bladder / Sample_Type by Project: Shred V9	PGM5 HMCN2 SYNM SOBP ITIH5 ELANE TNXB	9.83e-06	160	206	7	d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCell	Mild-Lymphoid-NK-CD8_T\|Mild / Condition, Lineage, Cell class and cell subclass	GIMAP5 DLG3 KIR3DL1 KIR3DL2 SH2D3C CD2 CELSR3	1.20e-05	165	206	7	9b0b037383e3e7cf7cfbc65b8d4c4721be3210f8
ToppCell	Endothelial-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP2 ABCA4 SMOC1 PGM5 TAL1 SYNM TNXB	1.25e-05	166	206	7	c286987ea4e511195607c87ec4529c2c2ed2122e
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZDHHC2 BDNF DLC1 SHH ATOH8 SRRM3 HSPB7	1.25e-05	166	206	7	2e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZDHHC2 BDNF DLC1 SHH ATOH8 SRRM3 HSPB7	1.25e-05	166	206	7	eb8d972326a734549675307e411fc795af66da70
ToppCell	Severe-Lymphoid-NK-CD8_T\|Severe / Condition, Lineage, Cell class and cell subclass	NFATC2 STARD9 KIR3DL1 KIR3DL2 FADS6 CD2 AUTS2	1.30e-05	167	206	7	8d41015871616ab7eced5104cd8f70d0efe504f2
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFATC2 ARHGEF37 PDZD4 SNED1 SNIP1 RAB34 CELSR3	1.35e-05	168	206	7	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 PALS1 TJP1 CCBE1 FMN2 PLCE1	1.35e-05	168	206	7	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	droplet-Fat-Bat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFATC2 ARHGEF37 PDZD4 SNED1 SNIP1 RAB34 CELSR3	1.35e-05	168	206	7	794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PGM5 STARD9 TAL1 SYNM RSPO1 TNXB HSPB7	1.35e-05	168	206	7	a97e8e07ba949b30805aeed5f60fa5e092b9d3d4
ToppCell	droplet-Fat-Bat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFATC2 ARHGEF37 PDZD4 SNED1 SNIP1 RAB34 CELSR3	1.35e-05	168	206	7	1e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	TPO GDF6 KIR3DL2 CRH CEACAM16	1.37e-05	66	206	5	6cf03dd1db7607684cdcca7df08933f8cdc3adef
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	TPO GDF6 KIR3DL2 CRH CEACAM16	1.37e-05	66	206	5	85e0027bf0d4ebdcb6cac358aedd1d74aa83c612
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PGM5 STARD9 TAL1 SYNM RSPO1 TNXB HSPB7	1.46e-05	170	206	7	516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PGM5 STARD9 TAL1 SYNM RSPO1 TNXB HSPB7	1.46e-05	170	206	7	cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PGM5 STARD9 TAL1 SYNM RSPO1 TNXB HSPB7	1.46e-05	170	206	7	0bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMOC1 NFATC2 PDZD4 TCF19 ALKBH2 POLD1 RAB34	1.63e-05	173	206	7	15af4a0f7516dbf5c93ba66a19aca073ebe30d04
ToppCell	Endothelial-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP2 PGM5 KCNG2 TAL1 PLA2G4C TNXB PLCE1	1.63e-05	173	206	7	a81992965137195d20fc498f750975303961a828
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 PALS1 TJP1 CCBE1 FMN2 PLCE1	1.89e-05	177	206	7	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 THSD1 SMOC1 PGM5 KCNG2 SH2D3C PLCE1	1.89e-05	177	206	7	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 THSD1 SMOC1 PGM5 KCNG2 SH2D3C PLCE1	1.89e-05	177	206	7	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP2 THSD1 SMOC1 PGM5 KCNG2 SH2D3C PLCE1	1.89e-05	177	206	7	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ST3GAL6 NPHS1 PALS1 TJP1 CCBE1 FMN2 PLCE1	1.96e-05	178	206	7	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZDHHC2 EPHB6 PDZD4 SHROOM3 RSPO1 TNXB PLCE1	1.96e-05	178	206	7	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	2.10e-31	46	210	20	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8	3.76e-27	69	210	20	DOID:1682 (implicated_via_orthology)
Disease	cortical thickness	CNNM2 B4GALNT1 ABCA4 GDF6 DLC1 GRIFIN MICAL3 PLEKHA7 DIP2B HSPG2 SHROOM3 SHH ITIH5 VPS13D KANSL1 ADAMTS7 AUTS2 FMN2 ANKFN1 PLCE1 PDZD2	5.02e-05	1113	210	21	EFO_0004840
Disease	NEPHROTIC SYNDROME, TYPE 3	NPHS1 PLCE1	5.04e-05	2	210	2	C1853124
Disease	Bipolar Disorder	TPO BDNF STARD9 DLG3 CACNA1A CACNA1C HIP1R SLC1A6 CRH CRY1 NR2E1 PCNT	1.73e-04	477	210	12	C0005586
Disease	Schizophrenia	DLGAP2 DLGAP1 CNNM2 BDNF DLG3 CACNA1C SLC1A6 CRH ACTR2 PNPO PLA2G4C WDR11 NR2E1 AUTS2 TNXB PCNT	6.25e-04	883	210	16	C0036341
Disease	Antihypertensive use measurement	ZNRF3 NFATC2 CACNA1C DIP2B HSPG2 STIM2 AUTS2 PLCE1	6.57e-04	265	210	8	EFO_0009927
Disease	depressive symptom measurement	DLGAP2 HIVEP1 ERCC4 KCNG2 MEX3B NUP160 TRHDE CACNA1A KSR2 TNXB	1.02e-03	426	210	10	EFO_0007006
Disease	Hydrops Fetalis, Non-Immune	THSD1 CCBE1	1.03e-03	7	210	2	C0455988
Disease	suberic acid measurement	ANKFN1 PDZD2	1.03e-03	7	210	2	EFO_0010534
Disease	myoclonic-atonic epilepsy (implicated_via_orthology)	ROBO3 VARS1	1.03e-03	7	210	2	DOID:0060475 (implicated_via_orthology)
Disease	autism spectrum disorder (is_marker_for)	BDNF SHH	1.03e-03	7	210	2	DOID:0060041 (is_marker_for)
Disease	Obesity, Morbid	BDNF KSR2	1.03e-03	7	210	2	C0028756
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	NUP160 NPHS1 PLCE1	1.25e-03	30	210	3	C1868672
Disease	cerebellar ataxia (implicated_via_orthology)	PNPLA6 CACNA1A	1.37e-03	8	210	2	DOID:0050753 (implicated_via_orthology)
Disease	Fanconi anemia (implicated_via_orthology)	ERCC4 FAN1	1.37e-03	8	210	2	DOID:13636 (implicated_via_orthology)
Disease	Microphthalmia associated with colobomatous cyst	GDF6 SHH	1.37e-03	8	210	2	C2931501
Disease	temporal lobe epilepsy (biomarker_via_orthology)	CACNA1A SHH CRH	1.38e-03	31	210	3	DOID:3328 (biomarker_via_orthology)
Disease	diffuse scleroderma	DDX6 TNPO3	1.76e-03	9	210	2	EFO_0000404
Disease	axial length measurement	CNNM2 ZNRF3 ANKFN1 RSPO1	2.25e-03	77	210	4	EFO_0005318
Disease	eotaxin measurement	MICAL3 SRRM3 GASK1A PDZD2	2.59e-03	80	210	4	EFO_0008122
Disease	kidney disease (implicated_via_orthology)	KIRREL2 NPHS1 PALS1	3.10e-03	41	210	3	DOID:557 (implicated_via_orthology)
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	KIR2DS4 KIR3DL2	3.17e-03	12	210	2	EFO_0008197
Disease	coffee consumption measurement, tea consumption measurement	BDNF ZC3H4 NUP160	3.80e-03	44	210	3	EFO_0006781, EFO_0010091
Disease	alcohol use disorder (biomarker_via_orthology)	BDNF CRH	4.34e-03	14	210	2	DOID:1574 (biomarker_via_orthology)
Disease	Neurodevelopmental Disorders	DLGAP1 ZC3H4 PLXNB1 WDFY3	4.44e-03	93	210	4	C1535926
Disease	obesity (implicated_via_orthology)	ITPR3 CORO7 PLXNB1 STIM2 SDK2 CRH	4.53e-03	215	210	6	DOID:9970 (implicated_via_orthology)
Disease	schizophrenia, anorexia nervosa	CNNM2 CACNA1C INA	4.86e-03	48	210	3	MONDO_0005090, MONDO_0005351
Disease	Tinnitus, wellbeing measurement	NFATC2 SLX9 ANKFN1 CAPN15	4.97e-03	96	210	4	EFO_0007869, HP_0000360
Disease	cleft lip (is_implicated_in)	GDF6 KIF7	4.98e-03	15	210	2	DOID:9296 (is_implicated_in)
Disease	response to olanzapine	HIVEP1 CACNA1C	4.98e-03	15	210	2	GO_0097333
Disease	complement factor H-related protein 4 measurement	TPO TAF7 KSR2	5.15e-03	49	210	3	EFO_0600091
Disease	alcohol use disorder measurement, alcohol consumption measurement	BDNF NUP160 CACNA1C AUTS2	5.16e-03	97	210	4	EFO_0007878, EFO_0009458
Disease	idiopathic scoliosis (implicated_via_orthology)	KATNB1 KIF7	5.66e-03	16	210	2	DOID:0060250 (implicated_via_orthology)
Disease	attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder	CNNM2 ERCC4 KCNG2	5.76e-03	51	210	3	EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090
Disease	Psychotic Disorders	BDNF CACNA1C SOBP PCNT	5.95e-03	101	210	4	C0033975
Disease	oral motor function measurement	DLGAP1 SHROOM3	6.39e-03	17	210	2	EFO_0021793
Disease	nervous system disorder	BDNF PNPLA6 NFATC2	6.41e-03	53	210	3	C0027765

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSVGVRPRTTERHIA	TRHDE	21	Q9UKU6
PVLERIRDHVSGVTG	ALKBH2	136	Q6NS38
GEQRHPFDALRRTTI	CACNA1A	411	O00555
RLDDTVHVVIATPGR	DDX6	211	P26196
GAPRERVHREEERTA	C1orf167	466	Q5SNV9
VRHAGVQTSRPISRD	CDR2L	381	Q86X02
VRRHSDPARRGELSV	BDNF	126	P23560
THPERIAGRGIRIRD	ABCA4	141	P78363
EIHERRRSSAMGPRG	SH3BP5	256	O60239
VREVGFDPRLSRVAH	B4GALNT1	446	Q00973
PDREGRASEDRSLLH	ARHGEF37	16	A1IGU5
LAALRQRHAEPSRVG	INA	126	Q16352
FASHGRGDRELVVLR	ANK1	996	P16157
HTGREAVRPDGSLDI	CEACAM16	81	Q2WEN9
PDGRVLARHGIRREE	CEACAM16	181	Q2WEN9
TRAHRVATEERGRKP	CD2	251	P06729
ERNGRVSIRDHPEAL	CD300E	71	Q496F6
DVRDDARSGRPVTHR	GVQW3	56	Q3ZCU0
ARSGRPVTHRTDDNI	GVQW3	61	Q3ZCU0
TAVEHRSDSPGRIRH	DLGAP1	126	O14490
AAAEQRSESPGRIRH	DLGAP2	216	Q9P1A6
LRHGADPEVRDTTGL	ANKRD61	96	A6NGH8
GADTVIFERLHRRGA	ATP8B3	661	O60423
GADVNRRDRIHESSP	ASB6	126	Q9NWX5
PHLTRRLDIAGRDIT	ACTR2	176	P61160
ATEGRAALDIVHPVR	ADAMTS7	36	Q9UKP4
QLGHEDTTSLDRPRR	RCCD1	331	A6NED2
SPERTQVHAGRTVRL	HSPG2	1961	P98160
RARDEAGVPRLHQSS	QRICH2	151	Q9H0J4
EGLDPNRTRASDRHG	QRICH2	961	Q9H0J4
TRRLAHGEELRFGAI	HAGHL	86	Q6PII5
PSLRRGHEVSERVQS	ITPR3	1846	Q14573
SREGEAHERRLRAVP	KIR3DL2	256	P43630
AIVHSRERENIPRGS	KIAA1107	841	Q9UPP5
ISQIHERTGRRGPTV	PGM5	551	Q15124
IILLTESRGERHEGR	CAPN15	956	O75808
PARSSHQELRRDEGS	ARHGEF17	926	Q96PE2
EPRAVATNGLRDRTH	ATOH8	51	Q96SQ7
VRFGLPDSRRHGESI	RAB3GAP2	376	Q9H2M9
RVRLVFRVHIPESSG	NFATC2	541	Q13469
TESRLPQESRRVHLG	NPHS1	486	O60500
LLHREEGAGPTRTVE	PNPLA6	906	Q8IY17
HEIRGSRARALPDRA	EXOSC4	56	Q9NPD3
TLEHVRDQRPGLVRS	PTPRN	941	Q16849
SREGEAHERRLPAVR	KIR2DS4	161	P43632
AHERRLPAVRSINGT	KIR2DS4	166	P43632
HRGERPTLVSTLTDR	MICAL3	696	Q7RTP6
RPIRRITHISGTLED	LONP2	246	Q86WA8
RRAHTLEREVPGIEE	NCKAP5L	1171	Q9HCH0
HSSEQDGLRVPRQVR	ITIH5	26	Q86UX2
EREEVPRRSGLSAGH	MBD3	16	O95983
TLIVIRGHVPSDADR	LGALS8	31	O00214
LVAPRIRSSGVAREH	HMCN2	3221	Q8NDA2
IHRGDPARLVRTESV	KSR2	461	Q6VAB6
TRTGTVARDPVQDHR	KATNB1	306	Q9BVA0
DPHRLAVAGEDARIR	CORO7	556	P57737
SREGGAHERRLPAVR	KIR3DL1	256	P43629
HRDLGVPESRRPTVE	PLXNB1	1586	O43157
RRLRDVVDNPHSGLA	KCNG2	161	Q9UJ96
DGGEPRRSSTVRIHV	PCDHGA9	216	Q9Y5G4
VAGPHLERSEVDRGT	PDZD2	276	O15018
LERSEVDRGTEHRIP	PDZD2	281	O15018
SRDPEAGRRQHAEER	PDZD4	531	Q76G19
AEGLLRVHARLRDSG	TPO	346	P07202
GDTHTALDLRPDERR	DCAF11	251	Q8TEB1
SVDPRREHERGGHLD	AUTS2	1136	Q8WXX7
HDRVRLVERGAPQSL	DIP2B	1346	Q9P265
EGAPRTREETRDLVH	KIF7	1256	Q2M1P5
VRREPSSDVHSRLGV	NCBP3	511	Q53F19
EGSRRPEVEAALRHL	PLK5	166	Q496M5
TRPDRTHRQHLDDVG	KANSL1	741	Q7Z3B3
ARSSRGIEEAGPRAH	LAPTM4B	36	Q86VI4
EADLGATGHRPRTEL	GPR152	6	Q8TDT2
PAGRRREQESVSGHL	LMNTD2	6	Q8IXW0
DPGIRDRHGRSALHR	ANKRD65	261	E5RJM6
LHDRIVFRRGLPTGD	PNPO	226	Q9NVS9
EVREIGPLSRRGFHL	EPHA10	176	Q5JZY3
QRLGGPASRHRVSED	P3H2	126	Q8IVL5
LGGHQEAPERERRSE	CRH	141	P06850
AGDRRIPAHRLVLSS	KLHL5	226	Q96PQ7
EVPGSRLHLGSARRA	PCNT	2946	O95613
LAAGRVALSTHRVRP	PHKG2	316	P15735
EVRARVRAAHGIPDL	METTL27	11	Q8N6F8
LDSGVDVHEARPARR	FAM171A2	686	A8MVW0
VIERLGREREGSFHS	GIMAP5	206	Q96F15
VPHTTRSRRDQEVAG	PALS1	511	Q8N3R9
ERRRVRGHEAFSIPG	FBXO38	116	Q6PIJ6
LREDGSLTIRARRHP	HSPB7	141	Q9UBY9
IRADPQGGRRRHSSE	IRS2	1136	Q9Y4H2
VTPLDGSVDVDEHRR	MLXIP	186	Q9HAP2
GSVDVDEHRRPEAIT	MLXIP	191	Q9HAP2
GRLVRTHPERDLTFL	PLA2G4C	221	Q9UP65
RRVEAERPHSLIGVI	FAM189A2	431	Q15884
DLRHPGRVRRDITLS	GASK1A	111	Q9UFP1
VLSRRPGHSLEAERE	HIP1R	11	O75146
SRARVGDTVRILVHG	IGSF21	351	Q96ID5
ESRAERVRLHGVPPD	KLHL21	71	Q9UJP4
AGLRTLHDIGPEIRR	CACNA1C	1701	Q13936
HGRRARRLDPSEAAT	EBF4	241	Q9BQW3
PRDLQGSRHRAEVAS	ATG9A	636	Q7Z3C6
GDDHPRRTETRDLRA	CCBE1	386	Q6UXH8
ERVDGSVRGEERHLA	CHD1L	391	Q86WJ1
PGGETEALTRLERHL	CRY1	211	Q16526
IAVRSGDAFHEIRPR	GALNT17	31	Q6IS24
EDEAAHSRGGRQTPR	MPG	131	P29372
VPHTTRPRRDNEVDG	DLG3	656	Q92796
EGLHREGRIETIPTA	SLC1A6	161	P48664
PAHVRGRTAVETDLT	BTBD7	1051	Q9P203
QRRPRRHSTEGEEGD	FBXO41	471	Q8TF61
RLRHPVLGTRADESQ	MAN1C1	151	Q9NR34
PREGILRVEVRHNSS	TMEM259	106	Q4ZIN3
SLGRARSVVHDLPVR	HUS1B	121	Q8NHY5
EEETGSREDRGPIVH	KIRREL2	566	Q6UWL6
RVVLGAHNLSRREPT	ELANE	81	P08246
IEHGVQPLGSRERET	CELSR3	111	Q9NYQ7
RPLGATTRVRVLSDH	GRIFIN	111	A4D1Z8
ARTPRVGGSAHLLER	FMN2	491	Q9NZ56
VLRESRSPDGAVHVV	SEC14L5	41	O43304
ATLGTESHPRIRLDR	SDK2	536	Q58EX2
TISIREDEVHRLGSP	SCNN1D	516	P51172
EGRAEAVLLRGDHTR	POLD1	976	P28340
APRRGHDNTGVTDRV	PEX1	946	O43933
PARSAHRGGEALLRE	FADS6	21	Q8N9I5
DAVQHERGPRTSTIR	NR2E1	86	Q9Y466
SRGFVVAVPEHRDRS	PAFAH2	126	Q99487
SREGEAHERRLPAGT	KIR2DS1	161	Q14954
AGEHHLARRVRSDPG	MEX3B	451	Q6ZN04
EGLADPEVRTGHRLS	FAN1	731	Q9Y2M0
EVHRGPARRSVLALT	PTGFRN	186	Q9P2B2
VDRGLDDLSHTPLRR	GDF6	131	Q6KF10
PEIRDVTRIERIGAH	RUVBL2	11	Q9Y230
AAVTRGDLRILPEAH	VARS1	691	P26640
GRHGIVRVDRVPLAS	TAF7	51	Q15545
VLTREDRPGGHIVAE	SRRM3	101	A6NNA2
GSRRRHRDGDVVLPA	SNIP1	11	Q8TAD8
RDGDRRLLPAAVHSV	SHH	321	Q15465
GRPRRTDLTVLVAHN	POLR2E	51	P19388
AREGSHEARVFRSIP	FARSA	71	Q9Y285
GVSRSFRHIRLGPTE	SYNM	1396	O15061
TRRGSPLLIGVRSEH	GFPT1	201	Q06210
VIIETGRAHPDSRRA	PLCE1	171	Q9P212
GELVLEGTFRVHRVR	PLEKHG3	301	A1L390
GRDAATAEARHRVPT	TAL1	76	P17542
VHFDPRQRGLTESRV	EPHB6	431	O15197
SREGGAHERRLPAVR	KIR3DS1	256	Q14943
HRPREVTVSLRATGL	PIK3R6	601	Q5UE93
RDRAVAGHLTRAVEP	NAGPA	86	Q9UK23
IAHARILERRASRPG	PHF12	151	Q96QT6
LPREATIIRHTSVRG	PLEKHA7	941	Q6IQ23
LTTRRATGRHEGVPT	RNF126	131	Q9BV68
RHVVERHGRDTSGPR	SLTM	951	Q9NWH9
GSEERTRRVLHAPVG	RSPO1	171	Q2MKA7
LGHEEEVGRRTTFRL	ST3GAL6	151	Q9Y274
EGHVDRSSQPTARRI	SIMC1	91	Q8NDZ2
LERSDVLAGPVHVRS	SHROOM3	1226	Q8TF72
APESHESRTGLEGRI	SHROOM4	671	Q9ULL8
GVRTETAPHIALDSR	SLC5A9	16	Q2M3M2
RIGVITNRERHPGSF	RPS4X	191	P62701
PHSGREGEIRHLFRS	SUPT5H	606	O00267
NRRRAGVVIDSSLPH	STARD9	466	Q9P2P6
VDDVTDPSIHLRGRG	SLC35F4	496	A4IF30
VELSGAERERPRHFR	NUP160	46	Q12769
LRRHVPDLESGSESG	DLC1	386	Q96QB1
LTSVDHDRAPVVGVR	DLC1	1446	Q96QB1
SGVRVSIRHPEALRD	SNED1	1036	Q8TER0
RILLRTGARESPHFV	ANKFN1	191	Q8N957
TEHERRRHSPGERGL	CNNM2	121	Q9H8M5
VRLPRGHRLELSDGD	TCF19	86	Q9Y242
HSESVSRGREPRALG	USP17L3	381	A6NCW0
GHRTTGPRFLISDRD	SMOC1	26	Q9H4F8
RVHEDLEGSSRGPVS	USP43	196	Q70EL4
RSSPRDLRDGEREHE	TRMT61B	41	Q9BVS5
DHSRILVGDSRGRVF	WDFY3	3421	Q8IZQ1
HSESVSRGREPRALG	USP17L4	381	A6NCW7
SPGDAEDRRELGLHR	TRPM5	11	Q9NZQ8
ISSPIGSHREEQEGR	RLF	1271	Q13129
ARGERRRHTIASGVD	SAPCD2	211	Q86UD0
ELVPRHLRGRRATGS	STIM2	16	Q9P246
TPAEHGRSEVVDLTR	SOBP	611	A7XYQ1
ASGRPRQRSHILEDD	WDHD1	366	O75717
HTPRNARDEGATGLR	RNF4	111	P78317
GARVATVREDPRAHR	ROBO3	101	Q96MS0
GLVAGIERTEPHRAR	THSD1	746	Q9NS62
VPGTRHSAVLRDLRS	TNXB	3711	P22105
HSESVSRGREPRALG	USP17L18	381	D6R9N7
HSESVSRGREPRALG	USP17L5	381	A8MUK1
RRLAGPRDSLIHVAA	VWA2	676	Q5GFL6
RSFPGRGSLERHLRE	ZNF646	1371	O15015
HSESVSRGREPRALG	USP17L21	381	D6R901
HSESVSRGREPRALG	USP17L13	381	C9JLJ4
DTAHGVERETPREGT	PRRC2B	881	Q5JSZ5
PRRRVASETHSEGSE	PRRC2B	1126	Q5JSZ5
HSESVSRGREPRALG	USP17L19	381	D6RCP7
TAPHSRGRDAVRESL	SH2B2	356	O14492
RGRDAVRESLIHVPL	SH2B2	361	O14492
VIAAEAPRRGRLHAV	TRIM72	361	Q6ZMU5
HSESVSRGREPRALG	USP17L1	381	Q7RTZ2
RATVVVGDLHPLRDA	SLX9	136	Q9NSI2
RDPRLTRHVEASGGS	ZC3H4	866	Q9UPT8
PEEVHSRSLRIGANR	TNPO3	151	Q9Y5L0
IHDPRSGRSGVVNRR	TJP1	136	Q07157
HSESVSRGREPRALG	USP17L12	381	C9JPN9
HSESVSRGREPRALG	USP17L24	381	Q0WX57
PHRGLGATREEERAL	ZNRF3	866	Q9ULT6
HSESVSRGREPRALG	USP17L7	381	P0C7H9
HSESVSRGREPRALG	USP17L8	381	P0C7I0
FDEVHRGLRRDSITP	ZNF800	306	Q2TB10
SRRLAHVGPRLRGET	SLX1A	91	Q9BQ83
EERPPRDVHSERAAG	SH2D3C	161	Q8N5H7
EREPRGEAHQEVLRR	ZDHHC2	96	Q9UIJ5
NVLSEDRRGPTRDFH	VPS33A	96	Q96AX1
FRSELPSLIHRRGID	ERCC4	691	Q92889
HSESVSRGREPRALG	USP17L6P	381	Q6QN14
IAGEEHPRGSILREV	WDR11	436	Q9BZH6
GAERPSFREETVRQH	SHE	346	Q5VZ18
HSESVSRGREPRALG	USP17L22	381	D6RA61
HSESVSRGREPRALG	USP17L15	381	C9J2P7
HSESVSRGREPRALG	USP17L17	381	D6RBQ6
SRVGVTGHVPLLERR	HIVEP1	1411	P15822
HSESVSRGREPRALG	USP17L2	381	Q6R6M4
HSESVSRGREPRALG	USP17L20	381	D6RJB6
HSESVSRGREPRALG	USP17L10	381	C9JJH3
HSESVSRGREPRALG	USP17L11	381	C9JVI0
RVGEEIREGTRHTLD	VPS13D	2621	Q5THJ4
RQDEHSGTRAEGSRP	RAB34	146	P0DI83
VRIVTLAPELGRSHE	AMDHD2	181	Q9Y303
GRSHEVIRALTARGI	AMDHD2	191	Q9Y303